Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 8354509 Antibodies to human programmed death receptor PD-1

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
June 13, 2008
0
Date of Patent
January 15, 2013
0
Patent Application Number
12663950
0
Patent Citations Received
‌
US Patent 12134654 Multispecific molecules and uses thereof
0
‌
US Patent 12091681 Ex vivo use of modified cells of leukemic origin for enhancing the efficacy of adoptive cell therapy
0
‌
US Patent 12103922 Macrocyclic complexes of alpha-emitting radionuclides and their use in targeted radiotherapy of cancer
0
‌
US Patent 12110330 Compositions of programmed death receptor 1 (PD-1) antibodies and methods of obtaining the compositions thereof
0
‌
US Patent 12121565 Methods of treatment of specific cancers with NLRP3 inhibitors and anti-PD1/PD-L1 antibodies
0
‌
US Patent 12122834 Anti-PD-1 antibodies
0
‌
US Patent 12123003 Synthetic RIG-I-like receptor agonists
0
‌
US Patent 11701357 Treatment of B cell cancers using a combination comprising Btk inhibitors
0
‌
US Patent 11702430 Aza-benzothiophene compounds as STING agonists
0
‌
US Patent 11707448 Combination therapies for the treatment of cancer
0
•••
Patent Inventor Names
Gradus Johannes Dulos
0
Gregory John Carven
0
Hans van Eenennaam
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
8354509
0
Patent Primary Examiner
‌
Ilia Ouspenski
0

Find more entities like US Patent 8354509 Antibodies to human programmed death receptor PD-1

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo